Form 4: Cidara Therapeutics Chief Scientific Officer Sells Shares to Cover Tax Obligations

Leslie Tari, Chief Scientific Officer of Cidara Therapeutics, sold 1,773 shares of common stock to cover tax withholding obligations related to the vesting and settlement of RSUs.

Summary

• On March 11, 2025, Leslie Tari, the Chief Scientific Officer of Cidara Therapeutics, sold 1,773 shares of common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting and settlement of Restricted Stock Units (RSUs).
• The shares were sold at a weighted average price of $21.9626, with individual transactions ranging from $21.96 to $22.26.
• Following the transaction, Tari directly owns 16,215 shares of Cidara Therapeutics common stock and indirectly owns 73 shares through a spouse.
• The reporting person also acquired 200 shares pursuant to the Issuer's Employee Stock Purchase Plan on November 20, 2024.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (sale of shares for tax obligations) and doesn't indicate any significant positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, reflecting insider transactions related to equity compensation. It's common for executives to sell shares to cover tax obligations when RSUs vest.

Stakeholder Impact

• The sale of shares by an executive could have a minor, temporary impact on the stock price, but is unlikely to be significant given the reason for the sale.

Key Dates